Solutions - Actoverco Campaigns

Login

فا

فا

Solutions

Presentation of Actover’s latest products at the Gastrointestinal and Liver Diseases Congress

January 29, 2025

Introduction of Two Progesterone Drugs by Ati Pharmed at the Royan International Congress

January 29, 2025

Production of the first drug approved by FDA for the treatment of severe alopecia areata in Iran

January 29, 2025

Helping to Treat Neuropathic Pain and Anemia with an Iranian Supplement

January 29, 2025

The combined diabetes medicine was produced by Iranian scientists!

January 29, 2025

Actoverco launches diabetes drug “Trytis”

January 29, 2025

Introduction of Actoverco Cardiovascular Medications at the 8th International Heart Failure Congress

January 29, 2025

Showcasing Actoverco's Diverse Product Range at the 23rd Annual Iranian Dermatologists Association Conference

January 29, 2025

Introduction of Two Progesterone Drugs by Ati Pharmed at the Royan International Congress

Actoverco

November 3, 2024

Actoverco’s Contribution to the 40th Annual Congress of the Iranian Psychiatric Association

Actoverco

November 3, 2024

Connect

Join Us

Our Brands

Our Events

Actoverco

Copyright © 2024–2028 Actoverco. All rights reserved.

Professional web design by Pars Pixels